As shown in Figure 3, The aptamer LC1 had relative strong bindings to the CD19-positive lymphoma cells Ramos (Figure 3A) and Raji (Figure 3B), whereas its bindings to the CD19-negative cells (Jurkat, and NB-4) were quite weak (Figure 3C & 3D). The gene discussed is CD19; the disease is lymphoma.